53 The triple immunostain cocktail recommended for diagnosing limited prostatic adenocarcinoma (2016 WHO, p.147) comprises
(A) AMACR/NKX3.1/high-molecular weight cytokeratin
(B)AMACR/p63/ high-molecular weight cytokeratin
(C)AE1/AE3/AMACR
(D)ERG/PSMA/NKX3.1

答案:登入後查看
統計: 尚無統計資料